Scientists will be able to detect cancer earlier from blood samples after advances were made in detecting microRNA molecules using gold-plated nanoparticles.
UNSW researchers have discovered a new way to detect ultralow levels of microRNA in a blood sample which could make diagnosis of cancer and other illnesses quicker and more efficient.
The research team used nanoparticles to latch on to the targeted microRNAs (miRNAs) which enabled them to be easily extracted. One of the main benefits was that it was effective even when the miRNA was in minuscule amounts in the blood sample. Previously, a much larger sample was needed to extract similar amounts.
MicroRNAs are short RNA molecules that target some messenger RNAs (genetic material used to synthesise proteins) to prevent them from coding for a specific protein. Impaired miRNA activity has been linked with the formation of cancerous tumours as well as metastasis, the spread of cancer to other parts of the body.
Scientia Professor Justin Gooding said the nanoparticles are, in effect, dispersible electrodes. When circulated through the blood they capture the miRNA before a magnet is used to recapture the nanoparticles with the newly attached microRNA.
“Now we get more of the microRNA because the dispersible electrodes capture nearly everything in the sample,” Professor Gooding said.
“Because the capture is so effective, we get higher sensitivities and can detect much lower limits.
“And since we bring them back to the electrode under a magnet, our response time is much faster.”
One of the advantages of being quicker is that it will cost less.
“It could be orders of magnitude cheaper. Our method takes 30 minutes compared with almost 12 hours for quantitative polymerase chain reaction,” Professor Gooding said.
Key to the new technology is not just the ability to detect lower concentrations of miRNA but the ability to detect a broad range of concentrations.
“This is really important to determine whether the levels of different microRNAs have increased or decreased,” Professor Gooding said.
“We can do this very quickly compared with the gold-standard nucleic acid amplification methods. And we can do it in unprocessed blood.
“What this means is the technology has the potential to determine the levels of microRNA just from a finger prick test.”
Professor Gooding said he would expect the technology to be available within three years, pending regulatory approvals.
The new diagnostic technique follows on the heels of a similar advance made by another UNSW research team exploring cancer detection in the blood.
In that study, published in Nature Communications, a team of medical researchers led by Professor Chris Heeschen developed a new way to detect early-stage cancer tumour cells in the blood using a malaria protein. This method, which targeted individual cancer cells found in a blood sample, also used a magnet to retrieve all the targeted cancer cells.
Professor Gooding believes the two methods, while working on very different scales, would be very complementary as tools to diagnose cancer.
“The malaria protein technology works by detecting cancer cells, rare cells in particular. These are found in the blood also and so are also compatible with the liquid biopsy concept,” he said.
“We are detecting small molecules found in the blood which could also identify the type of cancer, while they are looking for rare cells that are responsible for the spread of cancer. The two technologies could work very well together.”
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- ‘Black breasts matter’: Black women speak out about breast cancer riskon October 8, 2020 at 2:18 pm
The day before she turned 30 and had planned to leave for a celebratory vacation, Sharonda Vincent felt a lump on her left breast while in the shower. She scheduled a last-minute appointment with a ...
- Coping with Metastatic Breast Cancer in the Age of COVID-19on October 8, 2020 at 10:25 am
The COVID-19 pandemic may pose particular challenges if you live with metastatic breast cancer. Find out what to do to get the care you need during this time.
- COVID-19 and canceron October 8, 2020 at 10:13 am
A survey of dozens of clinical investigators in March found that nearly 60 percent of respondents had halted screening and/or enrollment in certain trials, and that half of their institutions had ...
- New study sheds light on the best drug choices for some patients with advanced breast canceron October 8, 2020 at 6:57 am
Patients with metastatic breast cancer carrying a particular mutation fare better on one form of hormone therapy than another and can be identified using a blood test, according to a new study.
- A bandage with magnetic nanofibres that kills skin cancer cells with heaton October 8, 2020 at 6:56 am
Researchers from the Indian Institute of Science (IISc) have developed a non-invasive bandage made with magnetic nanofibres to treat skin cancer by administering heat to the tumor cells.
- Michigan PFAS activist has cancer, says she's not surprisedon October 8, 2020 at 4:08 am
A woman who was honored by the federal government for her environmental activism in western Michigan has been diagnosed with cancer.
- Ashkenazi Jews face a higher cancer risk because of the BRCA gene. It means 'scanxiety', surgery — and empowermenton October 7, 2020 at 12:45 pm
For most people, the risk of carrying the BRCA gene mutation is one in 400. For Ashkenazi Jews, that number is one in 40. It means making difficult decisions about surgery, screening and having kids.
- What coverage does Medicare provide for bladder cancer?on October 6, 2020 at 4:54 am
Medicare covers treatment and services relating to bladder cancer. Some out-of-pocket costs may apply. Read on for more information.
- Blood tests and cancer checks on the HIGH STREET: Hundreds of NHS 'one stop shop' diagnostic hubs are to be set up in town centres across the countryon October 1, 2020 at 5:15 pm
Cancer checks, heart scans and blood tests are set to be carried out in hundreds of NHS 'one stop shops' on high streets across the United Kingdom.
- This Japan Startup Is Using Deep Learning To Detect Early-Stage Cancer In Blood Sampleson September 30, 2020 at 8:26 am
Imagine going for a routine blood test during an annual health checkup and being able to select a screening option that could tell you whether you have early-stage cancer.
via Bing News